- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04717323
Precision Gait Retraining for Children With Cerebral Palsy
February 23, 2022 updated by: Altec Inc.
This project will develop the first sensor-based mobile Pelvic Assist Device (mPAD) that can deliver precise, adaptable, pelvic control to restore natural coordination of upper- and lower-limb movements during gait in children with Cerebral Palsy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Gait impairments hinder mobility for more than 760,000 children and adults living with cerebral palsy (CP) in the US.
Motor relearning is possible for these individual but typically requires numerous training sessions with a team of physical therapists and assistants to restore coupling between upper- and lower-body segments while assisting spastic uncoordinated limb movement to improve gait kinematics.
This clinical trial will meet the overall objective of testing the feasibility of developing a smart-robotic exoskeleton that is effective at providing guided pelvic assistance and support while biofeedback mediated training is facilitated under the supervision of a physiotherapist.
The project will test a novel tethered Pelvic Assist Device (TPAD) with integratable electromyographic (EMG) and inertial (IMU) biofeedback that is uniquely capable of delivering precise, adaptable, multi-degree-of-freedom pelvic control to promote natural intersegmental coupling, restore coordination of upper- and lower-limb movement, and improve normal gait kinematics in children with CP.
Because of its proximity to the center of mass and critical role in coordinating upper- and lower-limb control, the pelvis provides an ideal access point for physiotherapists to manually improve gait.
The investigators will test the hypothesis that accurate sensor-based metrics of gait can be derived from EMG and IMU wearable sensors to develop a biofeedback system for motor learning that are integratable with TPAD to develop a new mobile mPAD device that is compliant with the target population.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- Altec Inc.
-
-
New York
-
New York, New York, United States, 10032
- CUMC Harkness Pavillion
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria (children with CP):
- Children (6-18 years of age)
- Male or Female
- Confirmed diagnosis of Cerebral Palsy by a neurologist;
- CT or MRI imaging consistent with clinical presentation;
- Clinical evidence of preserved cognition as determined by the child's neurologist;
- Clinical evidence of Mild to Moderate spastic (pyramidal) diplegia as determined by the child's neurologist;
- Gross Motor Function Classification System (GMFS) GMFCS Level II ("walks with limitations. Limitations include walking long distances and balancing, but not as able as Level I to run or jump; may require use of mobility devices when first learning to walk, usually prior to age 4; and may rely on wheeled mobility equipment when outside of home for traveling long distances."
- Spasticity being controlled by pharmaceutical or surgical correction; or has Modified Ashworth scale (MAS) = 0-2 ("More marked increase in muscle tone through most of the range of motion (ROM), but affected part(s) easily moved
- Ambulatory without assistive devices (except for long distances or on uneven terrain).
- No allergies to skin tape such as Band-Aid.
Exclusion Criteria (children with CP):
- Inability to follow simple instructions in English, or through a Spanish-speaking translator;
- Medical history of other neurological conditions;
- Medical history of cardiac or respiratory complications, or disorders that would place the subject at risk for conducting the different motor activities;
- Contractures present in lower limb - evaluated based on Tardieu Scale test where joint range of motion is measured during slow velocity movements and where contracture is operationally defined as being present if the angle at the end of range is 5 -10 degrees less than full range at ankle; and 5 -20 degrees less than full range at hip and knee.
- Skin disorders that result in open lesions or hyper-sensitive/fragile skin, preventing the use of medical-grade adhesive tapes to secure the sensors to the skin;
- Unable to provide Informed Consent from subject and Assent from parent or guardian using English or Spanish-translation informed consent form.
Inclusion Criteria (healthy volunteers):
- Adults or Children (age≥6 y.o.)
- Male or Female;
- Able to walk independently and without assistive devices;
- No history of musculoskeletal or neurological disorders;
- Able to follow directions in English.
Exclusion criteria (healthy volunteers):
- Non-English speaker;
- Unable to walk independently and without assistive devices;
- Medical history of neurological or musculoskeletal conditions (arthritis, spondylosis, etc.);
- Inability to follow simple instructions;
- Unable to provide informed consent in English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients
Gait with and without pelvic assistance
|
Gait retraining device that applies pelvic forces and measures response
Other Names:
Gait with no pelvic assistance
|
Experimental: Controls
Gait with no pelvic assistance
|
Gait with no pelvic assistance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gait Metric Accuracy
Time Frame: 1 day
|
Measures the accuracy of identifying heel strike and toe off timing in % error when comparing measures from wearable sensors vs. motion capture
|
1 day
|
Pelvis Range of Motion During Walking
Time Frame: 1 day
|
Difference (in degrees) between pelvis range of motion during walking as detected by wearable sensors and motion capture
|
1 day
|
Muscle Activation During Walking
Time Frame: 1 day
|
Measures electromyographic (EMG) signals of trunk and lower limb muscles during gait which are necessary for designing and implementing a mobile pelvic assist device (mPAD) system with biofeedback
|
1 day
|
Rating of Perceived Difficulty
Time Frame: 1 day
|
Structured interviews will be used to grade the perception of difficulty in using the technology
|
1 day
|
Trunk Range of Motion During Walking
Time Frame: 1 day
|
Difference (in degrees) between trunk range of motion during walking as detected by wearable sensors and motion capture
|
1 day
|
Hip Range of Motion During Walking
Time Frame: 1 day
|
Difference (in degrees) between hip range of motion during walking as detected by wearable sensors and motion capture
|
1 day
|
Knee Range of Motion During Walking
Time Frame: 1 day
|
Difference (in degrees) between knee range of motion during walking as detected by wearable sensors and motion capture
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Paola Contessa, PhD, Altec Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 11, 2020
Primary Completion (Actual)
January 31, 2021
Study Completion (Actual)
January 31, 2021
Study Registration Dates
First Submitted
December 7, 2020
First Submitted That Met QC Criteria
January 15, 2021
First Posted (Actual)
January 22, 2021
Study Record Updates
Last Update Posted (Actual)
March 4, 2022
Last Update Submitted That Met QC Criteria
February 23, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mPAD Phase 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
De-identified individual participant data for all primary and secondary outcome measures will be made available
IPD Sharing Time Frame
Data will be available within 6 months of study completion
IPD Sharing Access Criteria
Data access requests will be made through conferencing
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Centre Médico-Chirurgical de Réadaptation des Massues...RecruitingCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
St Mary's University CollegeUniversity of GloucestershireUnknownCerebral Palsy | Cerebral Palsy Ataxic | Cerebral Palsy, MixedUnited Kingdom
-
Hilde FeysHasselt University; ETH Zurich; Curtin UniversityRecruitingHemiplegic Cerebral Palsy | Cerebral Palsy, SpasticBelgium
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...RecruitingDystonic Cerebral Palsy | Dyskinetic Cerebral PalsyUnited States
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
October 6 UniversityCompletedSpastic Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyEgypt
-
Marmara UniversityUnknownCerebral Palsy, Spastic | Cerebral Palsy, Spastic, DiplegicTurkey
Clinical Trials on mPAD (or TPAD) Pelvic Assist Device
-
Columbia UniversityCompleted
-
Stanford UniversityTauTona GroupEnrolling by invitationLaparoscopic SurgeryUnited States
-
Stanford UniversityTauTona GroupActive, not recruiting